비교리스트

 카트 문의
시장보고서
상품코드
1342707

세계의 차세대 시퀀싱 인포매틱스 시장 - 산업 규모, 동향, 경쟁, 기회 및 예측(2018-2028년)

Next Generation Sequencing Informatics Market-Global Industry Size, Share, Trends, Competition, Opportunity, & Forecast, 2018-2028 Segmented By Products & Services, Application, End User, Region
발행일: | 리서치사: TechSci Research | 페이지 정보: 영문 114 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 차세대 시퀀싱 인포매틱스 시장은 암 유병률 증가와 차세대 시퀀싱(NGS)의 임상 적용 증가로 인해 2024년부터 2028년까지 예측 기간 동안 괄목할 만한 성장세를 보일 것으로 예상됩니다.

Global Cancer Observatory에 따르면, 2020년 세계적으로 약 1,929만 2,789건의 새로운 암 사례가 보고됐습니다. 유방암, 폐암, 대장암, 전립선암, 위암 등이 2020년에 가장 많이 보고된 암 유형이었습니다. 또한, DNA 시퀀싱 샘플 수 증가, 차세대 시퀀싱(NGS) 인포매틱스 사용으로 인한 DNA 시퀀싱 비용 절감, 다양한 정부 이니셔티브, 임상 적용 증가, 차세대 시퀀싱(NGS)의 마이크로 어레이 기술 대체는 시장 성장에 기여하는 시장 성장에 기여하는 다른 요인들입니다.

만성질환의 유병률 증가

세계적으로 암은 사망 원인 1위입니다. 세계보건기구(WHO)에 따르면, 지난 5년간 세계적으로 약 5,055,287건의 암이 보고되었습니다. 이는 자외선과 전리방사선과 같은 물리적 발암물질, 석면, 담배 연기, 알코올, 아플라톡신(식품 오염물질), 비소(식수 오염물질)와 같은 화학적 발암물질, 기생충 감염과 건강에 해로운 생활습관 선택과 같은 생물학적 발암물질의 존재로 인해 발생합니다. 현재 의료 분야의 주요 문제는 암입니다. 새로운 암 치료법에 대한 수요는 세계 차세대 시퀀싱 인포매틱스 시장의 성장을 가속할 것으로 예상됩니다.

또한, HIV, 인유두종 바이러스, 결핵 등 치명적이고 잠재적인 치료법을 필요로 하는 새로운 바이러스성 질환 증가는 차세대 시퀀싱 인포매틱스 세계 시장 성장을 더욱 촉진할 것으로 예상됩니다. HIV에 감염되어 있습니다.

차세대 시퀀싱(NGS)을 위한 임상연구 증가

임상연구는 관찰연구와 임상시험의 두 가지 요소로 구성된 의학 연구입니다. 임상 연구 활동은 차세대 염기서열 분석(NGS)을 통해 바이러스 유전체 염기서열을 파악함으로써 인간의 건강 관리로 이어집니다. 차세대염기서열분석(NGS) 기술은 바이러스 유전체 변이와 그것이 인간 건강에 미치는 영향을 연구하는 데 중요한 역할을 하고 있으며, Clinical OMICS에 게재된 연구 논문에 따르면 2020년 약 8만 4,000개의 코로나 바이러스 유전체 염기서열이 Global Initiative to Share All Influenza Data(GISAID)에 업로드되었습니다. 또한, 전체 게놈 및 전사체 시퀀싱, 메타게놈과 같은 용도는 다양한 미생물 샘플의 특성 분석에 사용되고 있으며, 이는 세계 차세대 시퀀싱(NGS) 인포매틱스 시장의 성장을 가속할 것으로 예상됩니다.

DNA 마이크로어레이 기술의 대안

최근의 발전과 시퀀싱 비용의 급격한 하락으로 차세대 시퀀싱(Next Generation Sequencing, NGS)의 인기가 급상승하고 있습니다. 비용이 저렴해지고 방법이 더 간단하고 널리 보급됨에 따라 연구자들은 많은 게놈 응용 분야에서 마이크로어레이보다 차세대 시퀀싱(NGS)을 선택하게 되었습니다. 또한, 차세대 시퀀싱(NGS)은 더 높은 해상도와 게놈에 대한 종합적인 뷰를 제공할 수 있는 잠재력을 가지고 있습니다.

이러한 사실은 차세대 염기서열분석(NGS) 시퀀서를 인간 건강 치료에 활용하기 위해 세계적으로 많은 연구 개발이 이루어지고 있으며, 이를 통해 세계 차세대 염기서열분석(NGS) 인포매틱스 시장의 성장을 뒷받침하고 있다는 것을 보여줍니다.

사용 가능한 커스터마이징

TechSci Research는 주어진 시장 데이터를 사용하여 기업의 고유한 요구에 따라 맞춤화할 수 있는 서비스를 제공합니다. 보고서는 다음과 같은 커스터마이징이 가능합니다.

기업 소개

  • 추가 시장 진출기업(최대 5개사)에 대한 심층 분석 및 프로파일링

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 차세대 시퀀싱 인포매틱스 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 제품 및 서비스별(관리 컴퓨팅 툴, 상용 데이터 분석·데이터 분석·리포팅 툴, 차세대 시퀀싱(NGS) 인포매틱스 서비스, 실험실 정보 관리 시스템(LIMS))
    • 용도별(Drug Discovery, 유전자 스크리닝, 질병 진단, 기타)
    • 최종사용자별(병원 및 진단센터, 제약 기업 및 바이오테크놀러지 기업, 학술기관 및 연구기관)
    • 지역별(북미, 유럽, 아시아태평양, 남미, 중동 및 아프리카)
    • 기업별(2022년)
  • 시장 맵
    • 제품 및 서비스별
    • 용도별
    • 최종사용자별
    • 지역별

제6장 북미의 차세대 시퀀싱 인포매틱스 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 제품 및 서비스별
    • 용도별
    • 최종사용자별
    • 국가별
  • 북미 국가별 분석
    • 미국
    • 캐나다
    • 멕시코

제7장 유럽의 차세대 시퀀싱 인포매틱스 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 제품 및 서비스별
    • 용도별
    • 최종사용자별
    • 국가별
  • 유럽 국가별 분석
    • 독일
    • 프랑스
    • 영국
    • 이탈리아
    • 스페인

제8장 아시아태평양의 차세대 시퀀싱 인포매틱스 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 제품 및 서비스별
    • 용도별
    • 최종사용자별
    • 국가별
  • 아시아태평양 국가별 분석
    • 중국
    • 일본
    • 인도
    • 한국
    • 호주

제9장 남미의 차세대 시퀀싱 인포매틱스 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 제품 및 서비스별
    • 용도별
    • 최종사용자별
    • 국가별
  • 남미 국가별 분석
    • 브라질
    • 아르헨티나
    • 콜롬비아

제10장 중동 및 아프리카의 차세대 시퀀싱 인포매틱스 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 제품 및 서비스별
    • 용도별
    • 최종사용자별
    • 국가별
  • 중동 및 아프리카 국가별 분석
    • 아랍에미리트(UAE)
    • 사우디아라비아
    • 남아프리카공화국
    • 터키
    • 이집트

제11장 시장 역학

  • 성장 촉진요인
    • 만성질환 유병률 상승
    • 차세대 시퀀싱(NGS) 임상 연구 증가
    • DNA 마이크로어레이 기술 대체

제12장 과제

    • 차세대 시퀀싱(NGS) 실험을 시행하기 위한 훈련을 받은 임상 담당자 부족
    • 차세대 시퀀싱(NGS)에 대한 낮은상환율

제13장 시장 동향과 발전

제14장 경쟁 구도

  • Business Overview
  • Product Offerings
  • Recent Developments
  • Financials(As Reported)
  • Key Personnel
    • Abbott Laboratories, Inc.
    • F. Hoffmann-La Roche Ltd.
    • PerkinElmer, Inc.
    • SOPHiA GENETICS SA
    • Precigen, Inc.
    • QIAGEN N.V.
    • Illumina, Inc.
    • Agilent Technologies, Inc.
    • Eagle Genomics Limited
    • BGI Genomics Co., Ltd.

제15장 전략적 제안

LSH 23.11.06

Global Next Generation Sequencing (NGS) Informatics Market is anticipated to observe an impressive growth during the forecast period, 2024-2028 owing to growing prevalence of cancer and increase in clinical applications for Next Generation Sequencing (NGS). According to Global Cancer Observatory, in 2020, around 19,292,789 new cancer cases were reported worldwide. Breast Cancer, Lung Cancer, Colorectum Cancer, Prostate Cancer and Stomach Cancer were the most prevalent types of cancer cases reported in 2020. Additionally, increase in number of samples for DNA sequencing, reduced cost of DNA sequencing with the use of Next Generation Sequencing (NGS) informatics, various government initiatives, rising clinical applications, substitution of Microarray technology by Next Generation Sequencing (NGS) are other factors contributing to market growth.

The growing prevalence of new viral diseases has significantly increased the demand for Next Generation Sequencing (NGS) Informatics market. Additionally, growing research & development activities being initiated by various governments and pharmaceutical & biotechnology companies across the globe is further expected to create lucrative opportunities for the growth of Next Generation Sequencing (NGS) Informatics market in the coming years. In 2021, the research & development expenditure in the pharmaceutical industry across the globe was around USD238 billion.

Rise in Prevalence of Chronic Diseases

Globally, the cancer is the leading cause of death. According to World Health Organization, around 50,550,287 cases of cancer have been reported worldwide in the last five years. This is brought due to the presence of physical carcinogens like ultraviolet and ionising radiation, chemical carcinogens like asbestos, tobacco smoke, alcohol, aflatoxin (a food contaminant), and arsenic (a drinking water contaminant), and biological carcinogens like parasite infections and unhealthy lifestyle choices. A major issue in healthcare nowadays is cancer. The demand for novel cancer therapies is anticipated to fuel the expansion of the global Next Generation Sequencing (NGS) Informatics market.

Similarly, the increasing prevalence of new viral diseases such as HIV, Human Papillomavirus and Tuberculosis which are deadly and require a potential treatment is further expected to drive the growth of global Next Generation Sequencing (NGS) Informatics Market. As of 2021, globally around 38.4 million people were living with HIV.

Increase in Clinical Research for Next Generation Sequencing (NGS)

Clinical research is medical research constituting two components: observational studies, clinical trials. The clinical research activities result in taking care of the human health by identifying the viral genome sequence through Next Generation Sequencing (NGS). The Next Generation Sequencing (NGS) technique plays a vital role in studying the mutations in the viral genome and their impact on human health as well. According to a research article published in Clinical OMICS, 2020, approximately 84,000 viral genomic sequences of the coronavirus have been uploaded to the Global Initiative to Share All Influenza Data (GISAID). Additionally, the application like whole genome and transcriptome sequencing, metagenomics, etc. is used for the characterization of different microbial samples which in turn is expected to fuel the growth of Global Next Generation Sequencing (NGS) Informatics Market.

Substitution of DNA Microarray Technology

With recent advancements and a radical decline in sequencing costs, the popularity of next generation sequencing (Next Generation Sequencing (NGS)) has skyrocketed. As costs become less prohibitive and methods become simpler and more widespread, researchers are choosing Next Generation Sequencing (NGS) over microarrays for more of their genomic applications. Additionally, Next Generation Sequencing (NGS) has the potential to offer even higher resolution and a more comprehensive view of the genome.

This clearly indicates that a lot of R&D is being done across the globe for utilizing Next Generation Sequencing (NGS) sequencing for the treatment of human health, thereby supporting the growth of global Next Generation Sequencing (NGS) Informatics Market.

Market Segmentation

Global Next Generation Sequencing (NGS) Informatics Market can be segmented based on products & services, application, end user, region and competitional landscape. Based on products & services, the market can be categorized into storage and computing tools, commercial data analysis, data interpretation, and reporting tools, Next Generation Sequencing (NGS), laboratory information management systems (LIMS). Based on application, the market can be fragmented into drug discovery, genetic screening, disease diagnosis, and others. Based on end user, the market can be divided into hospitals and diagnostic centers, pharmaceutical and biotechnology companies, academic and research institutions.

Company Profiles

Abbott Laboratories, Inc., F. Hoffmann-La Roche Ltd., PerkinElmer, Inc., SOPHiA GENETICS SA, Precigen, Inc., QIAGEN N.V., Illumina, Inc., Agilent Technologies, Inc., Eagle Genomics Limited, BGI Genomics Co., Ltd. are some of the key players operating in the Global Next Generation Sequencing (NGS) Informatics Market.

Report Scope

In this report, Global Next Generation Sequencing (NGS) Informatics Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Next Generation Sequencing (NGS) Informatics Market, By Products & Services:

  • Storage and Computing Tools
  • Commercial Data Analysis
  • Data Interpretation, and Reporting Tools
  • Next Generation Sequencing (NGS)
  • Laboratory Information Management Systems (LIMS)

Next Generation Sequencing (NGS) Informatics Market, By Application:

  • Drug Discovery
  • Genetic Screening
  • Disease Diagnosis
  • Others

Next Generation Sequencing (NGS) Informatics Market, By End User:

  • Hospitals and Diagnostic Centers
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutions

Next Generation Sequencing (NGS) Informatics Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • South Africa
    • Turkey
    • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Next Generation Sequencing (NGS) Informatics Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Next Generation Sequencing (NGS) Informatics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Products & Services (Storage and Computing Tools, Commercial Data Analysis, Data Interpretation, and Reporting Tools, Next Generation Sequencing (NGS) Informatics Services, Laboratory Information Management Systems (LIMS))
    • 5.2.2. By Application (Drug Discovery, Genetic Screening, Disease Diagnosis, and Others)
    • 5.2.3. By End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Academic and Research Institutions)
    • 5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East, and Africa)
    • 5.2.5. By Company (2022)
  • 5.3. Market Map
    • 5.3.1. By Products & Services
    • 5.3.2. By Application
    • 5.3.3. By End User
    • 5.3.4. By Region

6. North America Next Generation Sequencing (NGS) Informatics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Products & Services
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Next Generation Sequencing (NGS) Informatics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Products & Services
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Next Generation Sequencing (NGS) Informatics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Products & Services
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Next Generation Sequencing (NGS) Informatics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Products & Services
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User

7. Europe Next Generation Sequencing (NGS) Informatics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Products & Services
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Next Generation Sequencing (NGS) Informatics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Products & Services
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
        • 7.3.1.2.4. By Country
    • 7.3.2. France Next Generation Sequencing (NGS) Informatics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Products & Services
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Next Generation Sequencing (NGS) Informatics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Products & Services
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Next Generation Sequencing (NGS) Informatics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Products & Services
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Next Generation Sequencing (NGS) Informatics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Products & Services
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End User

8. Asia-Pacific Next Generation Sequencing (NGS) Informatics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Products & Services
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Next Generation Sequencing (NGS) Informatics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Products & Services
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. Japan Next Generation Sequencing (NGS) Informatics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Products & Services
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. India Next Generation Sequencing (NGS) Informatics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Products & Services
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Next Generation Sequencing (NGS) Informatics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Products & Services
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Next Generation Sequencing (NGS) Informatics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Products & Services
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. South America Next Generation Sequencing (NGS) Informatics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Products & Services
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Next Generation Sequencing (NGS) Informatics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Products & Services
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. Argentina Next Generation Sequencing (NGS) Informatics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Products & Services
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. Colombia Next Generation Sequencing (NGS) Informatics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Products & Services
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User

10. Middle East and Africa Next Generation Sequencing (NGS) Informatics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Products & Services
    • 10.2.2. By Application
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. UAE Next Generation Sequencing (NGS) Informatics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Products & Services
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Saudi Arabia Next Generation Sequencing (NGS) Informatics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Products & Services
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. South Africa Next Generation Sequencing (NGS) Informatics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Products & Services
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User
    • 10.3.4. Turkey Next Generation Sequencing (NGS) Informatics Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Products & Services
        • 10.3.4.2.2. By Application
    • 10.3.5. Egypt Next Generation Sequencing (NGS) Informatics Market Outlook
      • 10.3.5.1. Market Size & Forecast
        • 10.3.5.1.1. By Value
      • 10.3.5.2. Market Share & Forecast
        • 10.3.5.2.1. By Products & Services
        • 10.3.5.2.2. By Application
        • 10.3.5.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
    • 11.1.1. Rise in Prevalence of Chronic Diseases
    • 11.1.2. Increase in clinical research for Next Generation Sequencing (NGS)
    • 11.1.3. Substitution of DNA Microarray Technology

12. Challenges

    • 12.1.1. Lack of trained clinical personnel for conducting Next Generation Sequencing (NGS) experiments
    • 12.1.2. Poor reimbursement rates for Next Generation Sequencing (NGS) across the globe

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Business Overview
  • 14.2. Product Offerings
  • 14.3. Recent Developments
  • 14.4. Financials (As Reported)
  • 14.5. Key Personnel
    • 14.5.1. Abbott Laboratories, Inc.
    • 14.5.2. F. Hoffmann-La Roche Ltd.
    • 14.5.3. PerkinElmer, Inc.
    • 14.5.4. SOPHiA GENETICS SA
    • 14.5.5. Precigen, Inc.
    • 14.5.6. QIAGEN N.V.
    • 14.5.7. Illumina, Inc.
    • 14.5.8. Agilent Technologies, Inc.
    • 14.5.9. Eagle Genomics Limited
    • 14.5.10. BGI Genomics Co., Ltd.

15. Strategic Recommendations

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제